National Vulnerability Database

National Vulnerability Database

National Vulnerability
Database

CVE-2007-6763 Detail

Current Description

SAS Drug Development (SDD) before 32DRG02 mishandles logout actions, which allows a user (who was previously logged in) to access resources by pressing a back or forward button in a web browser.

Source:  MITRE
View Analysis Description

Impact

CVSS v3.0 Severity and Metrics:

Base Score: 8.8 HIGH
Vector: AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H (V3 legend)
Impact Score: 5.9
Exploitability Score: 2.8


Attack Vector (AV): Network
Attack Complexity (AC): Low
Privileges Required (PR): Low
User Interaction (UI): None
Scope (S): Unchanged
Confidentiality (C): High
Integrity (I): High
Availability (A): High

CVSS v2.0 Severity and Metrics:

Base Score: 6.5 MEDIUM
Vector: (AV:N/AC:L/Au:S/C:P/I:P/A:P) (V2 legend)
Impact Subscore: 6.4
Exploitability Subscore: 8.0


Access Vector (AV): Network
Access Complexity (AC): Low
Authentication (AU): Single
Confidentiality (C): Partial
Integrity (I): Partial
Availability (A): Partial
Additional Information:
Allows unauthorized disclosure of information
Allows unauthorized modification
Allows disruption of service

References to Advisories, Solutions, and Tools

By selecting these links, you will be leaving NIST webspace. We have provided these links to other web sites because they may have information that would be of interest to you. No inferences should be drawn on account of other sites being referenced, or not, from this page. There may be other web sites that are more appropriate for your purpose. NIST does not necessarily endorse the views expressed, or concur with the facts presented on these sites. Further, NIST does not endorse any commercial products that may be mentioned on these sites. Please address comments about this page to nvd@nist.gov.

Hyperlink Resource
http://ftp.sas.com/techsup/download/hotfix/drugdev/32drg02/SDD_Release_Notes_32DRG02.pdf Vendor Advisory

Technical Details

Vulnerability Type (View All)

  • Improper Input Validation (CWE-20)

Known Affected Software Configurations Switch to CPE 2.2

Configuration 1 ( hide )
 cpe:2.3:a:sas:sas_drug_development:*:*:*:*:*:*:*:*
     Show Matching CPE(s)
Up to (excluding)
32drg02


Change History

1 change record found - show changes

Quick Info

CVE Dictionary Entry:
CVE-2007-6763
NVD Published Date:
07/31/2019
NVD Last Modified:
08/11/2019